Navigation Links
SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
Date:10/10/2008

SAN DIEGO, CA, Oct. 10, 2008 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage and ingredient supply industries, noted today that Senomyx Scientific Founder, University of California, San Diego Professor and Howard Hughes Medical Institute Investigator Roger Y. Tsien, Ph.D., has been awarded the Nobel Prize in Chemistry for 2008 by The Royal Swedish Academy of Sciences. Dr. Tsien shares the prize with two other scientists for their work on "the discovery and development of the green fluorescent protein, GFP."

"Senomyx congratulates Roger on receiving the most prestigious award for scientific endeavors," remarked Mark Zoller, Ph.D., Senomyx's Chief Scientific Officer and Executive Vice President of Discovery and Development. "Roger continues to perform a valuable role for the Company as a member of the Senomyx Scientific Advisory Board."

Dr. Tsien, who is Professor of Pharmacology and Chemistry/Biochemistry at UC San Diego, was selected by the Nobel Prize Committee for his seminal contributions regarding understanding the chemistry of the fluorescence properties of GFP and other members of the GFP family. The originally isolated GFP protein provided a way to mark cells expressing specific genes and to follow the trafficking of proteins within cells. Work performed in Dr. Tsien's UC San Diego laboratory determined the mechanism by which GFP exhibits its green color and led to the development of a series of GFP variants that emit additional colors. This set of GFP proteins expanded the utility of GFP to study multiple proteins in the same cell.

Importantly, the modified GFPs developed by Dr. Tsien provided the means to analyze protein-protein interactions and changes in protein structure, such as the binding of ligands by receptors. Many of Dr. Tsien's discoveries have resulted in issued patents covering the use of GFP for these applications. Senomyx has licensed the use of patented GFP technology in the flavor and fragrance field.

"Senomyx is privileged to have benefitted from Dr. Tsien's scientific expertise and advice since the establishment of the Company," said Kent Snyder, President and Chief Executive Officer of Senomyx. "We appreciate his scientific guidance and applaud his being named a new Nobel Laureate."

About Senomyx, Inc. (http://www.senomyx.com)

Senomyx is a leading company using proprietary taste receptor technologies to discover and develop novel flavor ingredients in the savory, sweet, salt, bitter, and cooling areas. Senomyx has entered into product discovery and development collaborations with seven of the world's leading food, beverage, and ingredient supply companies: Ajinomoto Co., Inc., Cadbury Schweppes, Campbell Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA, and Solae. Nestle is currently marketing products that contain one of Senomyx's flavor ingredients. For more information, please visit http://www.senomyx.com.

Contact:

Gwen Rosenberg

Senomyx, Inc.

Vice President, Investor Relations & Corporate Communications

(858) 646-8369

gwen.rosenberg@senomyx.com


'/>"/>
SOURCE Senomyx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc.
2. SENOMYX ANNOUNCES EXTENSION OF DISCOVERY AND DEVELOPMENT COLLABORATION WITH CADBURY PLC
3. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE
6. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
7. Logical Therapeutics Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine
8. Blake M. Paterson MD, CEO and Co-founder of Alba Therapeutics, Wins Greater Baltimore Committee 2008 Leadership in Bioscience Award
9. ARUP Laboratories CEO and Co-Founder Announces Retirement
10. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):